TOPIC 423 (PHASE II): AN INTEGRATED MULTI-LEVEL DECISION SUPPORT PLATFORM TO ADDRESS PATIENT-CENTERED AND EVIDENCE-BASED SOCIAL DETERMINANTS OF HEALTH AMONG CANCER PATIENTS.

主题 423（第二阶段）：综合多级决策支持平台，解决以患者为中心、循证的癌症患者健康社会决定因素。

• 批准号: 10936287
• 负责人: CUPID CHAN
• 金额: $ 204.72万
• 依托单位: PISTEVO DECISION LLC
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-11 至 2025-09-10
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10936287
• 关键词: Address; Advanced Malignant Neoplasm; Appointments and Schedules; Authorization documentation; Cancer Burden; Cancer Patient; Caring; Censuses; Clinical; Clinical Decision Support Systems; Communication; Communities; Consultations; Data; Development; Electronic Health Record; Environment; Evaluation; Health; Health Resources; Healthcare Systems; Hospitals; Individual; Instruction; Interview; Notification; Oncology; Operative Surgical Procedures; Outcome; Patients; Persons; Phase; Production; Provider; Randomized, Controlled Trials; Resources; Schedule; Site; Social Workers; Societies; Software Engineering; Testing; Time; Treatment outcome; Visit; Writing; cancer health disparity; cancer therapy; comparative; digital; disparity reduction; evidence base; evidence based guidelines; health data; hospital readmission; improved; mobile application; patient health information; patient oriented; satisfaction; social epidemiology; social health determinants; treatment adherence

A strong body of evidence suggests that addressing Social Determinants of Health (SDH) within healthcare systems advances cancer treatment adherence and reduces disparities in outcomes; however, few studies actually intervene and provide resources to meet cancer patients’ SDH. Integrating SDH with clinical information within operational Clinical Decision Support (CDS) systems built into Electronic Health Records (EHR) is an essential approach for addressing cancer disparities. We propose: (1) Providing a fully functional product with patient-facing and provider-facing interfaces to address SDH needs, (2) Testing it in a randomized controlled trial to assess its impact on cancer patient clinical endpoints and user satisfaction, and (3) Integrating it into the production environment in both academic and community-based hospitals to evaluate its use in a real-world setting. Our approach combines expertise from software engineering, oncology, and social epidemiology. Our solution will enhance oncology practice by collecting relevant SDH information from patients and recommending evidence-based clinical actions addressing patient SDH needs, resulting in improved cancer treatment outcomes. Our solution will connect patients to actual resources to meet their SDH needs and streamline communication with decision support for patients and their care teams, potentially reducing disparities and the burden of cancer on the patient and society.

大量证据表明，在医疗保健系统中解决健康的社会决定因素（SDH）可以促进癌症治疗依从性并减少结果的差异;然而，很少有研究实际干预并提供资源来满足癌症患者的SDH。将SDH与内置于电子健康记录（EHR）中的操作临床决策支持（CDS）系统内的临床信息集成是解决癌症差异的重要方法。我们建议：（1）提供一个功能齐全的产品，具有面向患者和面向提供者的界面，以满足SDH需求，（2）在随机对照试验中对其进行测试，以评估其对癌症患者临床终点和用户满意度的影响，以及（3）将其集成到学术和社区医院的生产环境中，以评估其在现实环境中的使用。我们的方法结合了软件工程，肿瘤学和社会流行病学的专业知识。我们的解决方案将通过收集患者的相关SDH信息并建议基于证据的临床行动来满足患者的SDH需求，从而改善癌症治疗结果，从而增强肿瘤学实践。我们的解决方案将患者与实际资源连接起来，以满足他们的SDH需求，并简化与患者及其护理团队决策支持的沟通，从而可能减少差异以及癌症对患者和社会的负担。